brian-kilmeade-2
On Air Now
1071-talk-radio-logo-white%402x-png
The Brian Kilmeade Show
Weekdays 10AM-Noon

David Schoen | 02-22-26

Roger Stone interviews attorney David Schoen to analyze the legal challenges and economic policies surrounding Donald Trump’s presidency and post-term litigation. Schoen defends the validity of presidential tariff authority despite recent judicial setbacks, arguing that the administration has multiple statutory paths to maintain its trade agenda without causing financial instability. The conversation transitions into a critical examination of "lawfare" in New York, where Schoen highlights procedural flaws and alleged judicial bias in the hush money and civil fraud cases. Finally, the pair discusses Department of Justice integrity by advocating for the pardon of Michael Sessa and Vic Orena, using their convictions to illustrate a broader narrative of prosecutorial misconduct involving figures like Andrew Weissman.

Learn more about your ad choices. Visit megaphone.fm/adchoices

 

More Episodes

The Roger Stone Show | 02-22-26

The Roger Stone Show Roger Stone blends personal narrative with aggressive political commentary to frame himself and President Donald Trump as victims of a corrupt establishment. Stone details his own legal battles and a recent...

Lara Logan | 02-22-26

The Roger Stone Show Roger Stone interviews investigative journalist Lara Logan to analyze the current American political landscape through the lens of accountability and information warfare. The dialogue centers on a clip from Susan Rice,...

Dinesh D’Souza | 02-22-26

The Roger Stone Show Roger Stone and Dinesh D’Souza engage in a critical dialogue regarding the hidden history and character of Steve Bannon, painting him as a deceptive and self-serving figure within the conservative movement....

Dr. Patrick Soon-Shiong | 02-15-26

The Roger Stone Show Roger Stone interviews Dr. Patrick Soon-Shiong, a prominent surgeon and entrepreneur, regarding a breakthrough cancer treatment called Anktiva. Dr. Patrick explains that the drug utilizes a molecule known as IL-15, which...

Loading...